A patient with polycystic kidney disease (PKD) presents with elevated creatinine and BUN levels, indicating impaired renal function, along with anemia. Which nursing intervention is the most appropriate to address the patient's anemia?

B) Administer erythropoiesis-stimulating agents as prescribed

A) Increase dietary iron intake through patient education

B) Administer erythropoiesis-stimulating agents as prescribed

C) Encourage increased fluid intake to improve hydration

D) Monitor for signs of infection and report findings

A patient with polycystic kidney disease (PKD) presents with anemia, recurrent urinary tract infections, and elevated creatinine levels. Which of the following nursing interventions should be prioritized to address the patient's anemia?

A) Administer prescribed erythropoiesis-stimulating agents

B) Encourage increased fluid intake to prevent further dehydration

C) Initiate a low-protein diet to reduce renal workload

D) Provide education on avoiding high-potassium foods

A patient with polycystic kidney disease presents with increased fatigue, decreased urine output, and laboratory findings indicating hyperkalemia and worsening renal function. Which nursing intervention is the most important to implement first?

B) Restrict dietary potassium intake

A) Administer erythropoiesis-stimulating agent as prescribed

B) Restrict dietary potassium intake

C) Monitor blood pressure closely and adjust antihypertensive medications

D) Educate the patient about the signs and symptoms of uremic syndrome

A patient with polycystic kidney disease presents with increased fatigue, elevated blood pressure, decreased urine output, and laboratory findings indicating worsening renal function and hyperkalemia. Which nursing intervention is most appropriate to address the patient's current condition?

B) Educate the patient on reducing dietary potassium intake.

A) Encourage a high-protein diet to combat anemia.

B) Educate the patient on reducing dietary potassium intake.

C) Increase fluid intake to improve urine output.

D) Suggest the use of non-steroidal anti-inflammatory drugs (NSAIDs) for flank pain.

A patient with chronic kidney disease (CKD) is experiencing worsening anemia and hyperkalemia. The healthcare team has initiated management strategies including an erythropoiesis-stimulating agent (ESA), dietary modifications, and a calcium channel blocker. Two weeks later, the patient's hemoglobin and potassium levels have improved, but renal function continues to decline. Which nursing intervention is most important to prioritize at this stage?

C) Discuss with the patient the implications of declining renal function and potential future treatments.

A) Educate the patient about the importance of adhering to a low-potassium diet.

B) Monitor the patient for potential side effects of the erythropoiesis-stimulating agent.

C) Discuss with the patient the implications of declining renal function and potential future treatments.

D) Reinforce the importance of taking antihypertensive medications as prescribed.

A patient with chronic kidney disease (CKD) has recently started an erythropoiesis-stimulating agent (ESA) and dietary modifications to manage anemia and hyperkalemia. During a follow-up visit, her hemoglobin levels have marginally increased, and serum potassium levels have decreased. However, her glomerular filtration rate (GFR) continues to decline. What should be the nurse's priority intervention at this time?

C) Reinforce the importance of medication adherence and regular follow-up visits to manage CKD progression.

A) Educate the patient on the importance of adhering to fluid restrictions to prevent fluid overload.

B) Encourage the patient to increase protein intake to improve nutritional status.

C) Reinforce the importance of medication adherence and regular follow-up visits to manage CKD progression.

D) Suggest the patient increase physical activity to help stabilize renal function.

A patient with chronic kidney disease presents with increased blood pressure, pitting edema, and shortness of breath. Recent lab results indicate a declining GFR and elevated serum creatinine levels, suggesting worsening renal function. Which nursing intervention is most appropriate to address the patient's current symptoms while considering her renal status?

B) Initiate diuretic therapy to manage fluid overload and reduce edema.

A) Increase the dosage of the calcium channel blocker to better control blood pressure.

B) Initiate diuretic therapy to manage fluid overload and reduce edema.

C) Encourage a high-protein diet to improve serum albumin levels and decrease edema.

D) Administer supplemental oxygen to alleviate shortness of breath and improve oxygenation.

A patient with chronic kidney disease presents with fatigue, increased lower extremity swelling, and shortness of breath. Her blood pressure is elevated, and she exhibits pitting edema and fine crackles in her lungs. Given her declining renal function and symptoms of fluid overload, which nursing intervention is the priority to prevent further complications?

B) Administer prescribed diuretics and monitor urine output closely.

A) Encourage increased fluid intake to maintain hydration.

B) Administer prescribed diuretics and monitor urine output closely.

C) Implement a high-protein diet to improve serum albumin levels.

D) Advise the patient to perform vigorous exercise to reduce edema.

A patient with worsening renal function and pulmonary congestion is admitted to the hospital. The healthcare team initiates intravenous loop diuretics. Which nursing intervention is most critical to monitor for potential complications in this patient?

D) Assessing for signs of electrolyte imbalance, particularly potassium levels.

A) Monitoring daily weight and intake/output closely.

B) Encouraging increased oral fluid intake to support renal function.

C) Educating the patient on the importance of dietary sodium restriction.

D) Assessing for signs of electrolyte imbalance, particularly potassium levels.

undiagnosed polycystic kidney disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Polycystic kidney disease (PKD) is primarily caused by genetic mutations in the PKD1 or PKD2 genes, leading to abnormal cell signaling and dysregulated cell proliferation. This results in the formation of numerous fluid-filled cysts in the kidneys, which progressively enlarge and disrupt normal renal architecture and function.

• Secondary mechanism: The expanding cysts compress surrounding renal tissues, leading to ischemia, inflammation, and fibrosis. This further exacerbates the loss of functional nephrons and contributes to a decline in glomerular filtration rate (GFR), eventually progressing to chronic kidney disease (CKD).

• Key complication: As renal function declines, patients may experience hypertension, hematuria, and increased risk of renal failure, necessitating ongoing monitoring and management to prevent or delay end-stage renal disease (ESRD).

Patient Profile

Demographics:

45-year-old female, office manager

History:

• Key past medical history: Hypertension, recurrent urinary tract infections

• Current medications: Lisinopril 10 mg daily, Hydrochlorothiazide 25 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent flank pain and increasing abdominal girth

• Key symptoms: Frequent urination, blood in urine, fatigue, occasional headaches

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial assessment, the medical team ordered a series of diagnostic tests to further investigate the patient's symptoms and underlying polycystic kidney disease (PKD). A renal ultrasound revealed multiple bilateral renal cysts with some measuring up to 5 cm in diameter. The ultrasound also indicated mild hydronephrosis, suggesting partial obstruction of urine flow, likely due to the enlarged cysts. A CT scan of the abdomen confirmed the presence of these cysts and further highlighted the compromised renal parenchyma. Blood tests showed a reduced glomerular filtration rate (GFR) of 45 mL/min/1.73 m², indicating stage 3 chronic kidney disease. Additionally, the patient's creatinine level was elevated at 1.8 mg/dL, and blood urea nitrogen (BUN) was 32 mg/dL, both reflecting impaired renal function.

The urinalysis results were consistent with the patient's complaints, showing microscopic hematuria and mild proteinuria. These findings, combined with the recurrent urinary tract infections, suggested a potential for developing urinary tract complications, possibly stemming from cyst rupture or infection. The patient's anemia, with a hemoglobin level of 10.5 g/dL, indicated the potential for erythropoietin deficiency due to declining renal function. This constellation of diagnostic findings highlighted the progressive nature of the patient's PKD and underscored the need for a comprehensive management plan to address both renal and extrarenal manifestations.

These results necessitate a multidisciplinary approach involving nephrology, urology, and potentially genetic counseling to manage the current complications and prevent further decline. The healthcare team must now prioritize interventions aimed at optimizing blood pressure control, managing pain, and addressing the anemia. This will involve considering adjustments to the patient's antihypertensive regimen and potentially initiating erythropoiesis-stimulating agents. Moreover, the patient will need close monitoring for any signs of further renal deterioration or additional complications, such as infections or electrolyte imbalances, which could indicate progression toward end-stage renal disease (ESRD). The integration of these findings will guide the next steps in the patient's treatment plan and ongoing care.

Section 2

Change in Patient Status:

A few weeks after the initial diagnostic results and the commencement of an adjusted management plan, the patient returned for a follow-up visit. During this visit, she reported experiencing increased fatigue, a decrease in urine output, and a dull, persistent flank pain on both sides. She also mentioned episodes of nausea and a noticeable decrease in her appetite, which had led to a slight weight loss. On examination, her blood pressure was elevated at 150/95 mmHg, despite adherence to the antihypertensive regimen. Her heart rate was slightly tachycardic at 98 beats per minute, and mild peripheral edema was observed in the lower extremities.

Repeat laboratory tests revealed further deterioration in renal function, with a glomerular filtration rate (GFR) now reduced to 38 mL/min/1.73 m² and a serum creatinine level of 2.2 mg/dL. Her blood urea nitrogen (BUN) had also increased to 40 mg/dL. A complete blood count showed worsening anemia, with a hemoglobin level dropping to 9.8 g/dL. Electrolyte imbalances were noted, with a serum potassium level of 5.3 mEq/L, indicating hyperkalemia, which could pose additional cardiovascular risks. The urinalysis continued to show microscopic hematuria and proteinuria, and a new finding of granular casts suggested further tubular damage.

These changes in the patient's status indicate a progression of her polycystic kidney disease and the emergence of new complications that require immediate attention. The worsening anemia and hyperkalemia necessitate reevaluation of her treatment plan, potentially including the initiation of erythropoiesis-stimulating agents and dietary modifications to manage potassium levels. Additionally, the healthcare team must consider more aggressive measures to control her blood pressure, possibly involving the addition of another antihypertensive agent. The patient's symptoms and lab findings underscore the importance of close monitoring and may prompt discussions about the timing and need for renal replacement therapy in the future.

Section 3

Response to Interventions:

Following the identification of the new complications, the healthcare team promptly adjusted the patient's management plan. An erythropoiesis-stimulating agent (ESA) was initiated to address the worsening anemia, with close monitoring of hemoglobin levels to assess response and prevent any adverse events. Dietary modifications were also implemented to manage the hyperkalemia, including a low-potassium diet and the potential use of potassium binders if needed. A second antihypertensive agent, a calcium channel blocker, was added to her regimen to achieve better blood pressure control, aiming to decrease the risk of further renal damage and cardiovascular complications.

Within two weeks of these interventions, the patient returned for a follow-up assessment. She reported some improvement in energy levels and a slight increase in appetite, though she continued to experience occasional nausea. Blood pressure measurements showed a modest improvement, now averaging around 142/90 mmHg, and her heart rate had stabilized at approximately 88 beats per minute. Hemoglobin levels showed a marginal increase to 10.2 g/dL, indicating a positive response to the ESA, while serum potassium levels decreased to 4.8 mEq/L, suggesting effective dietary management.

Despite these encouraging signs, the patient's renal function continued to decline, with a GFR now at 35 mL/min/1.73 m² and a serum creatinine level of 2.4 mg/dL. These trends necessitated ongoing discussions regarding the potential need for renal replacement therapy in the near future. The healthcare team emphasized the importance of continued adherence to the management plan and regular monitoring to promptly address any further changes in her condition. This phase of the patient's journey highlighted the need for vigilant monitoring and flexible treatment strategies to adapt to the evolving nature of her disease.

Section 4

Two weeks after the initial follow-up, the patient presents to the clinic with new complaints of fatigue and increased swelling in her lower extremities. During the assessment, it was noted that her blood pressure has risen again to 150/95 mmHg, despite the addition of the calcium channel blocker. Her heart rate remains stable, but there is notable pitting edema in her ankles and feet. She reports experiencing shortness of breath with minimal exertion, a new development since her last visit. Auscultation of her lungs reveals fine crackles at the bases, suggesting fluid overload.

New diagnostic results show a declining GFR of 28 mL/min/1.73 m², and a serum creatinine level of 3.0 mg/dL, indicating further deterioration of renal function. The patient's serum albumin level has decreased to 3.2 g/dL, which may be contributing to the edema. A repeat complete blood count shows stable hemoglobin levels at 10.1 g/dL, although her white blood cell count is slightly elevated at 11,000/mm³, raising concerns about a potential underlying infection or inflammatory process.

Given these findings, the healthcare team is concerned about the progression to fluid overload and the possibility of heart failure. Diuretics are considered to manage the edema and symptoms of fluid retention, while also discussing the implications of this on renal function. The team emphasizes the need for a delicate balance in managing these complications to prevent exacerbating the patient's kidney disease. This development requires a reassessment of her treatment plan, with a focus on optimizing cardiovascular and renal outcomes while preparing for the potential need for more aggressive interventions, including the consideration of renal replacement therapy. The patient is educated on recognizing signs of worsening fluid overload and instructed to report any new symptoms immediately.

Section 5

The patient returns to the clinic one week later with worsening symptoms. She now reports severe fatigue, increased shortness of breath even at rest, and the swelling in her lower extremities has extended to her thighs. Her vital signs reveal a blood pressure of 160/100 mmHg, heart rate of 110 beats per minute, and respiratory rate of 28 breaths per minute with an oxygen saturation of 88% on room air. She appears pale and is using accessory muscles to breathe. Auscultation of her lungs shows worsening crackles throughout all lung fields, indicating significant pulmonary congestion.

Laboratory results show further decline in renal function with a GFR of 25 mL/min/1.73 m² and a serum creatinine level of 3.3 mg/dL. Her serum potassium is elevated at 5.8 mEq/L, raising concerns about hyperkalemia due to compromised renal excretion. The patient's serum albumin has decreased further to 2.9 g/dL, exacerbating the edema. A chest X-ray confirms pulmonary edema with bilateral pleural effusions. Given the risk of emergent complications, the healthcare team decides to admit the patient to the hospital for closer monitoring and aggressive management of her fluid overload and renal insufficiency.

In the hospital, the patient is started on intravenous loop diuretics to address the fluid overload, with close monitoring of her electrolyte levels to prevent further complications. The healthcare team discusses the need for careful titration to avoid rapid fluid shifts that could compromise her already tenuous renal function. Nephrology and cardiology consultations are requested to explore the need for renal replacement therapy and to optimize cardiovascular support. The patient and her family are counseled on these interventions and the potential for dialysis, preparing them for possible changes in her treatment plan as her condition evolves.